Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Rimcazole Clinical Trial at Shandon Clinic – IMB Report
Notice type:
3rd Party Publications
Date:
03/10/2011
Background Information Or Related Documents:
The Irish Medicines Board (IMB) has today published the findings of its investigation into the conduct of a clinical trial using rimcazole hemifumarate at the Shandon Clinic in August 2010.
This investigation was initiated by the IMB after three subjects participating in the trial experienced seizures. All three subjects recovered fully when the administration of the trial medication was discontinued.
The IMB is the competent authority for the regulation of medicines in Ireland. It is a statutory function of the IMB to assess applications from sponsors to conduct clinical trials.
Download:
IMB Rimcazole Trial Report
« Back
Date Printed: 16/05/2024